340B Report Publisher and CEO Ted Slafsky commends HRSA for its ceiling price website but encourages improvements to the site.

340B Publisher & CEO: 340B Ceiling Price Website Is Welcome Step but Needs Improvement

After a nine-year delay, federal officials in April 2019 did as Congress ordered and began posting 340B ceiling prices on a secure website. For the first time, providers enrolled in the 340B program had a tool to help them make sure they were not being overcharged.

Providers and their allies “praise the database as an essential tool to help ensure pricing accuracy,” 340B Report Publisher and CEO Ted Slafsky says in his latest blog post for Omnicell. Drug manufacturers’ public notices about refunds for 340B overcharges are way up, he notes. Federal auditors are finding more evidence of 340B overcharges—a sign the government uses the new system to check for and act on pricing discrepancies.

Providers and their allies praise the 340B ceiling price secure website, but it has limitations and can be made even better, 340B Report Publisher and CEO Ted Slafsky says in his latest blog post for Omnicell.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report